[PAR] QoQ Quarter Result on 30-Jun-2019 [#Q4]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
29-Jun-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q4]
Profit Trend
QoQ- -155.16%
YoY- -329.00%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 CAGR
Revenue 0 -826 826 2,956 28 2,660 22 -
PBT -20,730 -7,195 -5,104 -11,227 -4,400 -2,617 -3,573 79.59%
Tax -0 -826 826 2,956 0 0 0 -
NP -20,730 -7,195 -5,104 -11,227 -4,400 -2,617 -3,573 79.59%
Tax Rate - - - - - - - -
Total Cost 20,730 6,369 5,930 14,183 4,428 5,277 3,596 79.20%
Ratio Analysis
31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 CAGR
NP Margin 0.00 871.10 -617.95 -379.84 -15,637.06 -98.38 -15,998.41 -
Per Share
31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/12/17 CAGR
EPS -0.09 -0.03 -0.03 -0.08 -0.03 -0.02 -0.03 44.17%
EPS Diluted -0.09 -0.03 -0.03 -0.08 -0.03 -0.02 -0.03 44.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.